Hemizygous Le-Cre transgenic mice have severe eye abnormalities on some genetic backgrounds in the absence of LoxPSites

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Dorà, Natalie J ^a   Collinson, J Martin ^b   Hill, Robert E ^c   West, John D ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR PAX6; CRE RECOMBINASE; INTEGRASE;

ADULT; ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CRE GENE; DISEASE ASSOCIATION; DISEASE SEVERITY; EYE MALFORMATION; FEMALE; GENE DELETION; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENE FUNCTION; GENE SEQUENCE; GENETIC ASSOCIATION; HEMIZYGOSITY; LE GENE; LOXP SITE; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PAX6 GENE; TRANSGENE; TRANSGENIC MOUSE; ANIMAL; CBA MOUSE; GENETICS;

MUS MUSCULUS;

ANIMALS; EYE ABNORMALITIES; INTEGRASES; MICE; MICE, INBRED CBA; MICE, TRANSGENIC;

EID: 84907494908     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0109193     Document Type: Article

References (69)

1. Ashery-Padan R, Marquardt T, Zhou XL, Gruss P (2000). Pax6 activity in the lens primordium is required for lens formation and for correct placement of a single retina in the eye. Genes Dev 14: 2701-2711.
2. Dwivedi DJ, Pontoriero GF, Ashery-Padan R, Sullivan S, Williams T, et al. (2005). Targeted deletion of AP-2 alpha leads to disruption in corneal epithelial cell integrity and defects in the corneal stroma. Invest Ophthalmol Vis Sci 46: 3623-3630.
3. Garcia CM, Yu K, Zhao HT, Ashery-Padan R, Ornitz DM, et al. (2005). Signaling through FGF receptor-2 is required for lens cell survival and for withdrawal from the cell cycle during lens fiber cell differentiation. Dev Dyn 233: 516-527.
4. Smith AN, Miller LAD, Song N, Taketo MM, Lang RA (2005). The duality of β-catenin function: A requirement in lens morphogenesis and signaling suppression of lens fate in periocular ectoderm. Dev Biol 285: 477-489.
5. Liu W, Lagutin OV, Mende M, Streit A, Oliver G (2006). Six3 activation of Pax6 expression is essential for mammalian lens induction and specification. EMBO J 25: 5383-5395.
6. Swamynathan SK, Katz JP, Kaestner KH, Ashery-Padan R, Crawford MA, et al. (2007). Conditional deletion of the mouse Klf4 gene results in corneal epithelial fragility, stromal edema, and loss of conjunctival goblet cells. Mol Cell Biol 27: 182-194.
7. Swamynathan S, Kenchegowda D, Piatigorsky J, Swamynathan S (2011). Regulation of corneal epithelial barrier function by krüppel-like transcription factor 4. Invest Ophthalmol Vis Sci 52: 1762-1769.
8. Kenchegowda D, Swamynathan S, Gupta D, Wan H, Whitsett J, et al. (2011). Conditional disruption of mouse Klf5 results in defective eyelids with malformed meibomian glands, abnormal cornea and loss of conjunctival goblet cells. Dev Biol 356: 5-18.
9. Kenchegowda D, Harvey SAK, Swamynathan S, Lathrop KL, Swamynathan SK (2012). Critical role of Klf5 in regulating gene expression during post-eyelid opening maturation of mouse corneas. PLoS One 7: e0044771.
10. Joo JH, Kim YH, Dunn NW, Sugrue SP (2010). Disruption of mouse corneal epithelial differentiation by conditional inactivation of Pnn. Invest Ophthalmol Vis Sci 51: 1927-1934.
11. Kuracha MR, Burgess D, Siefker E, Cooper JT, Licht JD, et al. (2011). Spry1 and Spry2 are necessary for lens vesicle separation and corneal differentiation. Invest Ophthalmol Vis Sci 52: 6887-6897.
12. Maddala R, Chauhan BK, Walker C, Zheng Y, Robinson ML, et al. (2011). Rac1 GTPase-deficient mouse lens exhibits defects in shape, suture formation, fiber cell migration and survival. Dev Biol 360: 30-43.
13. Qu X, Hertzler K, Pan Y, Grobe K, Robinson ML, et al. (2011). Genetic epistasis between heparan sulfate and FGF-Ras signaling controls lens development. Dev Biol 355: 12-20.
14. Cammas L, Wolfe J, Choi S-Y, Dedhar S, Beggs H (2012). Integrin-linked kinase deletion in the developing lens leads to capsule rupture, impaired fiber migration and non-apoptotic epithelial cell death. Invest Ophthalmol Vis Sci 53: 3067-3081.
15. Garcia CM, Shui Y-B, Kamath M, DeVillar J, Johnson RS, et al. (2009). The function of VEGF-A in lens development: Formation of the hyaloid capillary network and protection against transient nuclear cataracts. Exp Eye Res 88: 270-276.
16. Chen Y, Doughman Y-q, Gu S, Jarrell A, Aota S-i, et al. (2008). Cited2 is required for the proper formation of the hyaloid vasculature and for lens morphogenesis. Development 135: 2939-2948.
17. Chen Y, Carlson EC, Chen ZY, Hamik A, Jain MK, et al. (2009). Conditional deletion of Cited2 results in defective corneal epithelial morphogenesis and maintenance. Dev Biol 334: 243-252.
18. Huang T-Q, Wang Y, Ebrahem Q, Chen Y, Cheng C, et al. (2012). Deletion of HIF-1α partially rescues the abnormal hyaloid vascular system in Cited2 conditional knockout mouse eyes. Mol Vis 18: 1260-1270.
19. +/2 small eye mice mimic human aniridia-related keratopathy. Invest Ophthalmol Vis Sci 44: 1871-1878.
20. Davis J, Duncan MK, Robison WG, Piatigorsky J (2003). Requirement for Pax6 in corneal morphogenesis: a role in adhesion. J Cell Sci 116: 2157-2167.
21. +/2 mouse. Invest Ophthalmol Vis Sci 45: 1101-1108.
22. +/2 mouse model of aniridia. Exp Eye Res 81: 224-235.
23. +/2 mouse cornea. Invest Ophthalmol Vis Sci 47: 1911-1917.
24. +/2 mouse model of epithelial wound-healing delay. BMC Biol 4: 27.
25. Beebe DC, Coats JM (2000). The lens organizes the anterior segment: Specification of neural crest cell differentiation in the avian eye. Dev Biol 220: 424-431.
26. Collinson JM, Quinn JC, Buchanan MA, Kaufman MH, Wedden SE, et al. (2001). Primary defects in the lens underlie complex anterior segment abnormalities of the Pax6 heterozygous eye. Proc Natl Acad Sci USA 98: 9688-9693.
27. Di Lullo E, Haton C, Le Poupon C, Volovitch M, Joliot A, et al. (2011). Paracrine Pax6 activity regulates oligodendrocyte precursor cell migration in the chick embryonic neural tube. Development 138: 4991-5001.
28. Davis-Silberman N, Kalich T, Oron-Karni V, Marquardt T, Kroeber M, et al. (2005). Genetic dissection of Pax6 dosage requirements in the developing mouse eye. Hum Mol Genet 14: 2265-2276.
29. Kroeber M, Davis N, Holzmann S, Kritzenberger M, Shelah-Goraly M, et al. (2010). Reduced expression of Pax6 in lens and cornea of mutant mice leads to failure of chamber angle development and juvenile glaucoma. Hum Mol Genet 19: 3332-3342.
30. Robinson ML, Walton NA, Wallace LM, Yang Y (2005). Homozygosity for the Le-Cre transgene is associated with microphthalmia and cataracts in the absence of other engineered genetic changes. Invest Ophthalmol Vis Sci 46 Supplement S: Meeting Abstract 1885.
31. Simpson TI, Pratt T, Mason JO, Price DJ (2009) Normal ventral telencephalic expression of Pax6 is required for normal development of thalamocortical axons in embryonic mice. Neural Dev 4, 19.
32. Quinn JC, West JD, Hill RE (1996). Multiple functions for Pax6 in mouse eye and nasal development. Genes Dev 10: 435-446.
33. Schedl A, Ross A, Lee M, Engelkamp D, Rashbass P, et al. (1996). Influence of Pax6 gene dosage on development - overexpression causes severe eye abnormalities. Cell 86: 71-82.
34. Chanas SA, Collinson JM, Ramaesh T, Dora N, Kleinjan DA, et al. (2009). Effects of elevated Pax6 expression and genetic background on mouse eye development. Invest Ophthalmol Vis Sci 50: 4045-4059.
35. Mort RL, Bentley AJ, Martin FL, Collinson JM, Douvaras P, et al. (2011) Effects of aberrant Pax6 gene dosage on mouse corneal pathophysiology and corneal epithelial homeostasis PLoS One 6: e28895.
36. Lobe CG, Koop KE, Kreppner W, Lomeli H, Gertsenstein M, et al. (1999). Z/AP, a double reporter for Cre-mediated recombination. Dev Biol 208: 281-292.
37. Hazlett L, Masinick S, Mezger B, Barrett R, Kurpakus M, et al. (1996). Ultrastructural, immunohistological and biochemical characterization of cultured mouse corneal epithelial cells. Ophthalmic Res 28: 50-56.
38. van Raamsdonk CD, Tilghman SM (2000). Dosage requirement and allelic expression of PAX6 during lens placode formation. Development 127: 5439-5448.
39. Leca4 missense mutation on eye development. Exp Eye Res 89: 263-273.
40. Yoshida S, Shimmura S, Kawakita T, Miyashita H, Den S, et al. (2006). Cytokeratin 15 can be used to identify the limbal phenotype in normal and diseased ocular surfaces. Invest Ophthalmol Vis Sci 47: 4780-4786.
41. +/2 mouse model of aniridia. PLoS One 8: e71117.
42. Dorà N, Ou J, Kucerova R, Parisi I, West JD, et al. (2008). PAX6 dosage effects on corneal development, growth and wound healing. Dev Dyn 237: 1295-1306.
43. Moyer PD, Kaufman AH, Zhang Z, Kao CWC, Spaulding AG, et al. (1996). Conjunctival epithelial cells can resurface denuded cornea, but do not transdifferentiate to express cornea-specific keratin 12 following removal of limbal epithelium in mouse. Differentiation 60: 31-38.
44. Liu CY, Zhu G, Westerhausenlarson A, Converse R, Kao CWC, et al. (1993). Cornea-specific expression of K12 keratin during mouse development. Curr Eye Res 12: 963-974.
45. Liu JJ, Kao WWY, Wilson SE (1999). Corneal epithelium-specific mouse keratin K12 promoter. Exp Eye Res 68: 295-301.
46. Shiraishi A, Converse RL, Liu CY, Zhou F, Kao CWC, et al. (1998). Identification of the cornea-specific keratin 12 promoter by in vivo particle-mediated gene transfer. Invest Ophthalmol Vis Sci 39: 2554-2561.
47. Kanakubo S, Nomura T, Yamamura KI, Miyazaki JI, Tamai M, et al. (2006). Abnormal migration and distribution of neural crest cells in Pax6 heterozygous mutant eye, a model for human eye diseases. Genes Cells 11: 919-933.
48. Schmidt-Supprian M, Rajewsky K (2007). Vagaries of conditional gene targeting. Nature Immunol 8: 665-668.
49. Smith L (2011). Good planning and serendipity: exploiting the Cre/Lox system in the testis. Reproduction 141: 151-161.
50. Harno E, Cottrell EC, White A (2013). Metabolic pitfalls of CNS Cre-based technology. Cell Metab 18: 21-28.
51. Rempe D, Vangeison G, Hamilton J, Li Y, Jepson M, et al. (2006). Synapsin I cre transgene expression produces germline recombination in male mice progeny. Genesis 44: 44-49.
52. Weng DY, Zhang Y, Hayashi Y, Kuan C-Y, Liu C-Y, et al. (2008). Promiscuous recombination of LoxP alleles during gametogenesis in cornea Cre driver mice. Mol Vis 14: 562-571.
53. Hebert JM, McConnell SK (2000). Targeting of cre to the Foxg1 (BF-1) locus mediates loxP recombination in the telencephalon and other developing head structures. Dev Biol 222: 296-306.
54. Thyagarajan B, Guimaraes MJ, Groth AC, Calos MP (2000). Mammalian genomes contain active recombinase recognition sites. Gene 244: 47-54.
55. Semprini S, Troup TJ, Kotelevtseva N, King K, Davis JRE, et al. (2007). Cryptic loxP sites in mammalian genomes: genome-wide distribution and relevance for the efficiency of BAC/PAC recombineering techniques. Nucleic Acids Res 35: 1402-1410.
56. Silver DP, Livingston DM (2001). Self-excising retroviral vectors encoding the Cre recombinase overcome Cre-mediated cellular toxicity. Mol Cell 8: 233-243.
57. Loonstra A, Vooijs M, Beverloo HB, Al Allak B, van Drunen E, et al. (2001). Growth inhibition and DNA damage induced by Cre recombinase in mammalian cells. Proc Natl Acad Sci USA 98: 9209-9214.
58. Baba Y, Nakano M, Yamada Y, Saito I, Kanegae Y (2005). Practical range of effective dose for Cre recombinase-expressing recombinant adenovirus without cell toxicity in mammalian cells. Microbiol Immunol 49: 559-570.
59. Janbandhu V, Moik D, Fässler R (2014). Cre recombinase induces DNA damage and tetraploidy in the absence of LoxP sites. Cell Cycle 13: 462-470.
60. Schmidt EE, Taylor DS, Prigge JR, Barnett S, Capecchi MR (2000). Illegitimate Cre-dependent chromosome rearrangements in transgenic mouse spermatids. Proc Natl Acad Sci USA 97: 13702-13707.
61. Pfeifer A, Brandon EP, Kootstra N, Gage FH, Verma IM (2001). Delivery of the Cre recombinase by a self-deleting lentiviral vector: Efficient gene targeting in vivo. Proc Natl Acad Sci USA 98: 11450-11455.
62. Forni PE, Scuoppo C, Imayoshi I, Taulli R, Dastru W, et al. (2006). High levels of Cre expression in neuronal progenitors cause defects in brain development leading to microencephaly and hydrocephaly. J Neurosci 26: 9593-9602.
63. Naiche LA, Papaioannou VE (2007). Cre activity causes widespread apoptosis and lethal anemia during embryonic development. Genesis 45: 768-775.
64. Thanos A, Morizane Y, Murakami Y, Giani A, Mantopoulos D, et al. (2012). Evidence for baseline retinal pigment epithelium pathology in the Trp1-Cre mouse. Am J Pathol 180: 1917-1927.
65. Lee JY, Ristow M, Lin XY, White MF, Magnuson MA, et al. (2006). RIP-Cre revisited, evidence for impairments of pancreatic beta-cell function. J Biol Chem 281: 2649-2653.
66. Buerger A, Rozhitskaya O, Sherwood MC, Dorfman AL, Bisping E, et al. (2006). Dilated cardiomyopathy resulting from high-level myocardial expression of Crerecombinase. J Card Fail 12: 392-398.
67. T2. J Immunol 182: 5633-5640.
68. Sey) mice. Anat Embryol 196: 311-321.
69. Festing MFW (1979) Inbred Strains in Biomedical Research. London: MacMillan Press. 483 p.